标题
Science gone translational: the OX40 agonist story
作者
关键词
-
出版物
IMMUNOLOGICAL REVIEWS
Volume 244, Issue 1, Pages 218-231
出版商
Wiley
发表日期
2011-10-21
DOI
10.1111/j.1600-065x.2011.01069.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Self-Antigen Prevents CD8 T Cell Effector Differentiation by CD134 and CD137 Dual Costimulation
- (2014) S. Bandyopadhyay et al. JOURNAL OF IMMUNOLOGY
- IL-12 Is Required for Anti-OX40-Mediated CD4 T Cell Survival
- (2014) C. E. Ruby et al. JOURNAL OF IMMUNOLOGY
- OX40 Costimulatory Signals Potentiate the Memory Commitment of Effector CD8+ T Cells
- (2014) S. F. Mousavi et al. JOURNAL OF IMMUNOLOGY
- OX40 Drives Protective Vaccinia Virus-Specific CD8 T Cells
- (2014) S. Salek-Ardakani et al. JOURNAL OF IMMUNOLOGY
- Immune Effects of Trastuzumab
- (2012) Marianna Nuti et al. Journal of Cancer
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Impact of tumour volume on the potential efficacy of therapeutic vaccines
- (2011) J. L. Gulley et al. Current Oncology
- 4-1BB Signaling Synergizes with Programmed Death Ligand 1 Blockade To Augment CD8 T Cell Responses during Chronic Viral Infection
- (2011) V. Vezys et al. JOURNAL OF IMMUNOLOGY
- Targeting OX40 Promotes Lung-Resident Memory CD8 T Cell Populations That Protect against Respiratory Poxvirus Infection
- (2011) S. Salek-Ardakani et al. JOURNAL OF VIROLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
- (2011) Antonella Sistigu et al. Seminars in Immunopathology
- Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
- (2010) Michael Croft Annual Review of Immunology
- Adoptive T cell therapy of cancer
- (2010) Malcolm K Brenner et al. CURRENT OPINION IN IMMUNOLOGY
- The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice
- (2010) Shahram Salek-Ardakani et al. JOURNAL OF CLINICAL INVESTIGATION
- OX40 is required for regulatory T cell–mediated control of colitis
- (2010) Thibault Griseri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- OX40 Ligand Regulates Inflammation and Mortality in the Innate Immune Response to Sepsis
- (2010) M. Karulf et al. JOURNAL OF IMMUNOLOGY
- Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice
- (2010) Michael J. Gough et al. JOURNAL OF IMMUNOTHERAPY
- Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
- (2010) Sara M. Mangsbo et al. JOURNAL OF IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade
- (2010) Jeffrey Weber SEMINARS IN ONCOLOGY
- Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge
- (2009) Vasileios Bekiaris et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo
- (2009) William L. Redmond et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Toll-like receptor agonists in cancer therapy
- (2009) Sylvia Adams Immunotherapy
- OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
- (2009) Daniel Hirschhorn-Cymerman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right
- (2009) C. E. Ruby et al. JOURNAL OF IMMUNOLOGY
- Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
- (2009) Nicola Normanno et al. Nature Reviews Clinical Oncology
- T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
- (2008) R. Houot et al. BLOOD
- OX40 Agonist Therapy Enhances CD8 Infiltration and Decreases Immune Suppression in the Tumor
- (2008) M. J. Gough et al. CANCER RESEARCH
- Multiple roles for CD4+T cells in anti-tumor immune responses
- (2008) Richard Kennedy et al. IMMUNOLOGICAL REVIEWS
- Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma
- (2008) John A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started